Published in BMC Gastroenterol on February 16, 2010
In Vivo and Ex Vivo Imaging Reveals a Long-Lasting Chlamydial Infection in the Mouse Gastrointestinal Tract following Genital Tract Inoculation. Infect Immun (2015) 0.85
Subjective food hypersensitivity: assessment of enterochromaffin cell markers in blood and gut lavage fluid. Int J Gen Med (2011) 0.75
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98
Functional bowel disorders and functional abdominal pain. Gut (1999) 7.63
Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev (1994) 4.94
Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide. Infect Immun (1984) 4.53
Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology (2002) 3.11
Chlamydial persistence: beyond the biphasic paradigm. Infect Immun (2004) 2.78
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology (2003) 2.39
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12
Postinfectious irritable bowel syndrome. Gastroenterology (2003) 2.12
Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility. Gut (2009) 2.05
A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A (2006) 2.01
Chronic pelvic pain in the community--symptoms, investigations, and diagnoses. Am J Obstet Gynecol (2001) 2.01
Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain. Am J Obstet Gynecol (2005) 1.49
New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis (2007) 1.39
'Candidatus Protochlamydia amoebophila', an endosymbiont of Acanthamoeba spp. Int J Syst Evol Microbiol (2005) 1.35
Mode of entry and release of chlamydiae in infections of intestinal epithelial cells. J Infect Dis (1972) 1.33
Contribution of sex-linked biology and gender roles to disparities with trachoma. Emerg Infect Dis (2004) 1.29
Chlamydia pneumoniae infection in human monocytes. Infect Immun (1999) 1.28
Rapid detection of the Chlamydiaceae and other families in the order Chlamydiales: three PCR tests. J Clin Microbiol (1999) 1.26
Chlamydia and associated arthritis. Curr Opin Rheumatol (2000) 1.25
Infections with the chlamydia-like microorganism Simkania negevensis, a possible emerging pathogen. Microbes Infect (2003) 1.25
The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population. A report from the Abdominal Symptom Study. Scand J Gastroenterol (1994) 1.22
Persistent chlamydial envelope antigens in antibiotic-exposed infected cells trigger neutrophil chemotaxis. J Infect Dis (1999) 1.17
Molecular mechanism of tryptophan-dependent transcriptional regulation in Chlamydia trachomatis. J Bacteriol (2006) 1.17
Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol (2002) 1.14
Irritable bowel syndrome in the gynecological clinic. Survey of 798 new referrals. Dig Dis Sci (1989) 1.14
Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil (2005) 1.10
Silencing or permanent activation: host-cell responses in models of persistent Chlamydia pneumoniae infection. Cell Microbiol (2005) 1.03
Is irritable bowel syndrome an inflammatory disorder? Curr Gastroenterol Rep (2008) 1.02
Autoimmunity to heat shock protein 60 and antigen-specific production of interleukin-10. Infect Immun (1997) 1.01
Persistent infection of Chlamydia in reactive arthritis. Ann Rheum Dis (2006) 0.99
Consequences of Citrobacter rodentium infection on enteroendocrine cells and the enteric nervous system in the mouse colon. Cell Microbiol (2006) 0.98
Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults. Clin Gastroenterol Hepatol (2007) 0.97
Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response. Arthritis Rheum (1998) 0.89
Studies of persistent infection by Chlamydia trachomatis serovar K in TPA-differentiated U937 cells and the role of IFN-gamma. J Med Microbiol (1998) 0.88
Optimised sample DNA preparation for detection of Chlamydia trachomatis in synovial tissue by polymerase chain reaction and ligase chain reaction. Ann Rheum Dis (2001) 0.86
Immunological aspects of genital chlamydia infections. Best Pract Res Clin Obstet Gynaecol (2002) 0.82
Intestinal lymphocytic epithelioganglionitis: a unique combination of inflammation in bowel dysmotility: a histopathological and immunohistochemical analysis of 28 cases. Histopathology (2009) 0.80
Chlamydia trachomatis infection: is it relevant in irritable bowel syndrome? Digestion (1998) 0.77
International staging system for multiple myeloma. J Clin Oncol (2005) 11.29
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology (2003) 3.66
Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology (2002) 3.11
Survival and growth of Francisella tularensis in Acanthamoeba castellanii. Appl Environ Microbiol (2003) 3.08
Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology (2010) 3.03
Aspirin for everyone older than 50? For. BMJ (2005) 3.02
Effectiveness of an early supplementation scheme of high-dose vitamin A versus standard WHO protocol in Gambian mothers and infants: a randomised controlled trial. Lancet (2007) 3.01
Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial. Am J Gastroenterol (2010) 2.30
Antimyeloma activity of heat shock protein-90 inhibition. Blood (2005) 2.24
The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. Am J Gastroenterol (2013) 2.21
Aspirin, salicylates, and cancer. Lancet (2009) 2.17
Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol (2011) 2.14
Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood (2003) 2.11
Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party. J Clin Oncol (2005) 1.97
The London Classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working Group. Gut (2010) 1.89
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J (2003) 1.81
A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life. Br J Haematol (2003) 1.81
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN). Blood (2011) 1.75
Effects of bone-targeted agents on cancer progression and mortality. J Natl Cancer Inst (2012) 1.69
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma. Haematologica (2014) 1.57
Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children. Blood (2008) 1.56
International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation. J Clin Oncol (2014) 1.52
Treatment of relapsed and refractory multiple myeloma in the era of novel agents. Cancer Treat Rev (2010) 1.48
Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group. Acta Neuropathol (2009) 1.48
Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy. Cancer Cell Int (2005) 1.46
Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival. BMC Med (2008) 1.40
Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype. Leuk Lymphoma (2008) 1.39
Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol (2013) 1.34
Vibrio cholerae O1 strains are facultative intracellular bacteria, able to survive and multiply symbiotically inside the aquatic free-living amoeba Acanthamoeba castellanii. FEMS Microbiol Ecol (2007) 1.34
Intracellular survival and replication of Vibrio cholerae O139 in aquatic free-living amoebae. Environ Microbiol (2005) 1.30
IMWG consensus on maintenance therapy in multiple myeloma. Blood (2012) 1.29
Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst (2013) 1.25
Essential role of proline isomerization in stefin B tetramer formation. J Mol Biol (2006) 1.23
A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol (2012) 1.21
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J Clin Oncol (2013) 1.19
Acute diarrhea in adults and children: a global perspective. J Clin Gastroenterol (2013) 1.15
Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol (2002) 1.14
Pseudomonas aeruginosa utilises its type III secretion system to kill the free-living amoeba Acanthamoeba castellanii. J Eukaryot Microbiol (2008) 1.13
A national DNA bank in The Gambia, West Africa, and genomic research in developing countries. Nat Genet (2004) 1.13
Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term. Biol Reprod (2008) 1.13
Randomized controlled trial of a treatment for anorexia and bulimia nervosa. Proc Natl Acad Sci U S A (2002) 1.10
Acanthamoeba castellanii an environmental host for Shigella dysenteriae and Shigella sonnei. Arch Microbiol (2008) 1.07
Functional status, health-related quality of life and symptom severity in patients with chronic intestinal pseudo-obstruction and enteric dysmotility. Scand J Gastroenterol (2009) 1.05
Current multiple myeloma treatment strategies with novel agents: a European perspective. Oncologist (2010) 1.04
Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. J Nutr (2010) 1.04
Chronic intestinal pseudo-obstruction due to buserelin-induced formation of anti-GnRH antibodies. Gastroenterology (2007) 1.03
Vibrio cholerae O139 requires neither capsule nor LPS O side chain to grow inside Acanthamoeba castellanii. J Med Microbiol (2009) 1.02
More patent protection for medicines with a new purpose. Nature (2010) 1.02
Increased prevalence of primary sclerosing cholangitis among first-degree relatives. J Hepatol (2005) 1.01
Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma. Haematologica (2011) 1.01
Birth season and environmental influences on blood leucocyte and lymphocyte subpopulations in rural Gambian infants. BMC Immunol (2008) 1.01
Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer (2003) 1.01
Electrogastrography: poor correlation with antro-duodenal manometry and doubtful clinical usefulness in adults. World J Gastroenterol (2007) 0.99
Comparison of the AF146527 and B1 repeated elements, two real-time PCR targets used for detection of Toxoplasma gondii. J Clin Microbiol (2009) 0.99
Autoantibodies in patients with gut motility disorders and enteric neuropathy. Scand J Gastroenterol (2007) 0.97
Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults. Clin Gastroenterol Hepatol (2007) 0.97
Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct. Catheter Cardiovasc Interv (2009) 0.96
Monsanto Technology LLC v. Cargill: a matter of construction. Nat Biotechnol (2008) 0.95
Detection of intraepithelial and stromal Langerin and CCR5 positive cells in the human endometrium: potential targets for HIV infection. PLoS One (2011) 0.95
Outcome of colectomy for slow-transit constipation in relation to presence of small-bowel dysmotility. Dis Colon Rectum (2004) 0.94
A glomus tumour: classic signs without magnetic resonance imaging findings. Scand J Plast Reconstr Surg Hand Surg (2005) 0.94
Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasia. J Clin Oncol (2010) 0.93
Multichannel electrogastrography (EGG) in normal subjects: a multicenter study. Dig Dis Sci (2004) 0.93
Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells. Transplantation (2006) 0.92
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma. Haematologica (2007) 0.92
New perspectives in the diagnosis and management of enteric neuropathies. Nat Rev Gastroenterol Hepatol (2013) 0.92
Narrow-band imaging magnifying endoscopy in adult patients with eosinophilic esophagitis/esophageal eosinophilia and lymphocytic esophagitis. Gastrointest Endosc (2013) 0.92
Antibodies against gonadotropin-releasing hormone (GnRH) and destruction of enteric neurons in 3 patients suffering from gastrointestinal dysfunction. BMC Gastroenterol (2010) 0.92
European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma. Leuk Lymphoma (2010) 0.91
Analysis of colorectal cancer morphology in relation to sex, age, location, and family history. J Gastroenterol (2012) 0.91
High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis. Arthritis Rheum (2002) 0.90
Risk factors for acute shunt blockage in children after modified Blalock-Taussig shunt operations. Heart Vessels (2010) 0.90
The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat. Transplantation (2007) 0.90
Idiopathic slow-transit constipation: an almost exclusively female disorder. Dis Colon Rectum (2003) 0.89
A randomised trial of a remote home support programme for infants with major congenital heart disease. Heart (2012) 0.89
Efficacy and outcome of autologous transplantation in rare myelomas. Haematologica (2010) 0.89
Detection of Vibrio cholerae and Acanthamoeba species from same natural water samples collected from different cholera endemic areas in Sudan. BMC Res Notes (2011) 0.89
Enteric ganglioneuritis and abnormal interstitial cells of Cajal: features of inflammatory bowel disease. Inflamm Bowel Dis (2007) 0.89
Protruding and non-protruding colon carcinomas originating in gut-associated lymphoid tissue. Anticancer Res (2010) 0.88
In functional dyspepsia, hypersensitivity to postprandial distention correlates with meal-related symptom severity. Gastroenterology (2013) 0.88
CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes. Haematologica (2012) 0.87
Depletion of enteric gonadotropin-releasing hormone is found in a few patients suffering from severe gastrointestinal dysmotility. Scand J Gastroenterol (2012) 0.87
Lenalidomide: a new therapy for multiple myeloma. Cancer Treat Rev (2008) 0.86
Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study. Dis Colon Rectum (2003) 0.86
Small intestinal manometry in patients with systemic sclerosis. Eur J Gastroenterol Hepatol (2005) 0.85
Multiple autophosphorylations significantly enhance the endoribonuclease activity of human inositol requiring enzyme 1α. BMC Biochem (2014) 0.85
Ante mortem diagnosis of amoebic encephalitis in a haematopoietic stem cell transplanted patient. Scand J Infect Dis (2009) 0.84
Inflammation as a cause of functional bowel disorders. Scand J Gastroenterol (2005) 0.84
ToxR of Vibrio cholerae affects biofilm, rugosity and survival with Acanthamoeba castellanii. BMC Res Notes (2012) 0.84
Interaction between Vibrio mimicus and Acanthamoeba castellanii. Environ Microbiol Rep (2010) 0.84
Expression of Luteinizing Hormone Receptor in the Gastrointestinal Tract in Patients with and without Dysmotility. Drug Target Insights (2012) 0.83
Findings in patients with chronic intestinal dysmotility investigated by capsule endoscopy. BMC Gastroenterol (2007) 0.83
Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells. Blood (2002) 0.83